09/05/2024 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 4:03 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 7:00 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 3:50 PM | Sarepta Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024 3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/25/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:35 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024 3:16 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 3:19 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 3:45 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 12:30 PM | BlackRock Inc. (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
05/06/2024 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/06/2024 7:09 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:05 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A | |
03/11/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:02 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 6:03 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:38 PM | Sarepta Therapeutics (Subject) Wigzell Hans Lennart Rudolf (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
03/05/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Nicaise Claude (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:34 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:55 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:42 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 3:47 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 12:34 PM | JANUS HENDERSON GROUP PLC (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024 4:26 PM | BlackRock Inc. (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024 11:08 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | INGRAM DOUGLAS S (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |